Customer:
BPL (UK)

Challenge:
Eliminating particulate in the manufacturing area is key to BPL's drive for consistently developing new and improved high quality plasma products, whilst maintaining the company's excellent safety record.

Solution:
Clean Zone and Work Zone were installed in a number of corridors leading to the critical areas. As part of a cGMP initiative, BPL tested for bacteria and yeast moulds and found them before and on the Dycem flooring, but no trace was found in the clean areas.

Statement:
A paper by Tim Sandle of BPL states: “Microbial counts into the access corridor significantly reduced, by approximately eighty percent, following the fitting of polymeric flooring. Therefore polymeric flooring can be a useful addition to a contamination control programme.”

Click here to return to Pharmaceutical.